163 related articles for article (PubMed ID: 34087977)
21. Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6.
Yang T; Qin J; Zhang Q; Sun H; Wang Z; Yang J; Liu H; Zhang C; Zhang S; Zhang J; Wang Y; Xu Y
Stem Cell Res; 2020 Apr; 44():101777. PubMed ID: 32229428
[TBL] [Abstract][Full Text] [Related]
22. Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis.
Chakraborty A; Tapryal N; Venkova T; Mitra J; Vasquez V; Sarker AH; Duarte-Silva S; Huai W; Ashizawa T; Ghosh G; Maciel P; Sarkar PS; Hegde ML; Chen X; Hazra TK
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8154-8165. PubMed ID: 32205441
[TBL] [Abstract][Full Text] [Related]
23. Homozygous spinocerebellar ataxia type 3 in China: a case report.
Chen Y; Li D; Wei M; Zhou M; Zhang L; Yu J; Qiu M; Jin Y; Lu X
J Int Med Res; 2021 Jun; 49(6):3000605211021370. PubMed ID: 34167352
[TBL] [Abstract][Full Text] [Related]
24. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
[TBL] [Abstract][Full Text] [Related]
25. Generation of human embryonic stem cell line chHES-472 from abnormal embryos diagnosed with Spinocerebellar ataxia type 3.
Liu L; Zeng S; Sun Y; Zhou X; Chen J; Du J; Lu G; Lin G; Ouyang Q
Stem Cell Res; 2016 Nov; 17(3):584-586. PubMed ID: 27934588
[TBL] [Abstract][Full Text] [Related]
26. Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.
Moore LR; Keller L; Bushart DD; Delatorre RG; Li D; McLoughlin HS; do Carmo Costa M; Shakkottai VG; Smith GD; Paulson HL
Stem Cell Res; 2019 Aug; 39():101504. PubMed ID: 31374463
[TBL] [Abstract][Full Text] [Related]
27.
Chen IC; Chang KH; Chen YJ; Chen YC; Lee-Chen GJ; Chen CM
Oxid Med Cell Longev; 2019; 2019():8130481. PubMed ID: 31687087
[TBL] [Abstract][Full Text] [Related]
28. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
[TBL] [Abstract][Full Text] [Related]
29. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease.
Malakhova AA; Grigor'eva EV; Malankhanova TB; Pavlova SV; Valetdinova KR; Abramycheva NY; Vetchinova AS; Illarioshkin SN; Zakian SM
Stem Cell Res; 2020 Apr; 44():101743. PubMed ID: 32179492
[TBL] [Abstract][Full Text] [Related]
30. Anti-Excitotoxic Effects of N-Butylidenephthalide Revealed by Chemically Insulted Purkinje Progenitor Cells Derived from SCA3 iPSCs.
Yang HH; Chiang IT; Liu JW; Hsieh J; Lee JH; Lu HE; Tso HS; Deng YC; Kao JC; Wu JR; Harn HJ; Chiou TW
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163312
[TBL] [Abstract][Full Text] [Related]
31. Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation.
Kondrateva E; Adilgereeva E; Amelina E; Tabakov V; Demchenko A; Ustinov K; Yasinovsky M; Voronina E; Lavrov A; Smirnikhina S
Stem Cell Res; 2020 Oct; 48():101933. PubMed ID: 32777768
[TBL] [Abstract][Full Text] [Related]
32. Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer' s disease.
Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Wang Y; Xu Y
Stem Cell Res; 2021 May; 53():102267. PubMed ID: 33652304
[TBL] [Abstract][Full Text] [Related]
33. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
34. Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936.
Toombs J; Panther L; Ornelas L; Liu C; Gomez E; Martín-Ibáñez R; Cox SR; Ritchie SJ; Harris SE; Taylor A; Redmond P; Russ TC; Murphy L; Cooper JD; Burr K; Selvaraj BT; Browne C; Svendsen CN; Cowley SA; Deary IJ; Chandran S; Spires-Jones TL; Sareen D
Stem Cell Res; 2020 Jul; 46():101851. PubMed ID: 32450543
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
[TBL] [Abstract][Full Text] [Related]
36. Generation of two induced pluripotent stem cell lines, GZHMCi009-A and GZHMCi010-A, derived from peripheral blood mononuclear cells of two SCA3 patients with 14/74 CAG repeats of the ATXN3 mutation.
Yinghong Y; Qian L; Bing S; Yingjun X; Wenzhi H; Bangzhu C; Xiaofang S
Stem Cell Res; 2022 May; 61():102782. PubMed ID: 35421843
[TBL] [Abstract][Full Text] [Related]
37. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
38. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
[TBL] [Abstract][Full Text] [Related]
39. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
40. Generation of 3 spinocerebellar ataxia type 1 (SCA1) patient-derived induced pluripotent stem cell lines LUMCi002-A, B, and C and 2 unaffected sibling control induced pluripotent stem cell lines LUMCi003-A and B.
Buijsen RAM; Gardiner SL; Bouma MJ; van der Graaf LM; Boogaard MW; Pepers BA; Eussen B; de Klein A; Freund C; van Roon-Mom WMC
Stem Cell Res; 2018 May; 29():125-128. PubMed ID: 29656178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
